Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie W Lees

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Gastroenterology|December 11, 2008
Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationshipCarl A Anderson, Dunecan C O Massey, Jeffrey C Barrett, et al.
Ebiomedicine|January 1, 2025
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota researchNicola J Wyatt, Hannah Watson, Gregory R Young, et al.
Gut|March 23, 2021
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximabNicholas A Kennedy, James R Goodhand, Claire Bewshea, et al.
Nature Genetics|January 10, 2017
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel diseaseKatrina M de Lange, Loukas Moutsianas, James C Lee, et al.
Gut|June 10, 2020
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panelShahida Din, Alexandra Kent, Richard C Pollok, et al.
Nature Genetics|April 29, 2008
Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's diseaseSheila A Fisher, Mark Tremelling, Carl A Anderson, et al.
The Lancet. Gastroenterology & Hepatology|June 15, 2026
HLA-DRB1*01:03 in patients with inflammatory bowel disease: a genotype-phenotype association studyQian Zhang, Eathar Shakweh, Mohmmed Tauseef Sharip, et al.
Nature Communications|March 17, 2022
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumabSimeng Lin, Nicholas A Kennedy, Aamir Saifuddin, et al.
Gut|January 19, 2026
Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort studyNathan Constantine-Cooke, Beatriz Gros, Nikolas Plevris, et al.
Journal of Crohn'S & Colitis|November 9, 2023
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or TofacitinibZhigang Liu, James L Alexander, Kai Yee Eng, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Gastroenterology|December 11, 2008
Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationshipCarl A Anderson, Dunecan C O Massey, Jeffrey C Barrett, et al.
Ebiomedicine|January 1, 2025
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota researchNicola J Wyatt, Hannah Watson, Gregory R Young, et al.
Gut|March 23, 2021
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximabNicholas A Kennedy, James R Goodhand, Claire Bewshea, et al.
Nature Genetics|January 10, 2017
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel diseaseKatrina M de Lange, Loukas Moutsianas, James C Lee, et al.
Gut|June 10, 2020
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panelShahida Din, Alexandra Kent, Richard C Pollok, et al.
Nature Genetics|April 29, 2008
Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's diseaseSheila A Fisher, Mark Tremelling, Carl A Anderson, et al.
The Lancet. Gastroenterology & Hepatology|June 15, 2026
HLA-DRB1*01:03 in patients with inflammatory bowel disease: a genotype-phenotype association studyQian Zhang, Eathar Shakweh, Mohmmed Tauseef Sharip, et al.
Nature Communications|March 17, 2022
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumabSimeng Lin, Nicholas A Kennedy, Aamir Saifuddin, et al.
Gut|January 19, 2026
Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort studyNathan Constantine-Cooke, Beatriz Gros, Nikolas Plevris, et al.
Journal of Crohn'S & Colitis|November 9, 2023
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or TofacitinibZhigang Liu, James L Alexander, Kai Yee Eng, et al.
Pageof 10